Plantain Extract to Target Crohn’s Disease
UK-based ingredient supplier Provexis says it is developing a plantain-derived extract that may provide support for Crohn’s disease patients during remission.
UK-based ingredient supplier Provexis says it is developing a plantain-derived extract that may provide support for Crohn’s disease patients during remission.
“The new ingredient, which comes from a fiber found in plantain, works by inhibiting the interaction between Escherichia coli bacteria often found in Crohn’s disease patients and cells lining the intestine,” the company says. “As E. coli bacteria have been found to interrupt a number of immunological interactions, their inhibition could potentially have a range of therapeutic benefits for the patient.”
The company says it is currently conducting a randomized controlled study to examine the effects of the extract in maintaining remission in Crohn’s disease patients at four centers in the UK. It says that preliminary trials in healthy humans showed no significant adverse effects on markers of gastrointestinal health over a 21-day supplementation period.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.
